Description
Global myeloproliferative disorders drugs market size is expected to reach $11.15 Bn by 2028 at a rate of 3.9%, segmented as by type, primary myelofibrosis, polycythemia vera (pv), essential thrombocythemia (et)
Global myeloproliferative disorders drugs market size is expected to reach $11.15 Bn by 2028 at a rate of 3.9%, segmented as by type, primary myelofibrosis, polycythemia vera (pv), essential thrombocythemia (et)